Optimizing Clinical Study Designs for CAR-T Cell Therapy: Development of an Efficient Sampling Strategy Through...

Area of Science:

• Immunology
• Pharmacometrics
• Clinical Trial Design

Background:

• Chimeric antigen receptor T-cell (CAR-T) therapy shows promise in hematological cancers but faces challenges with patient response durability.
• Understanding dose-exposure and exposure-response relationships is key to optimizing CAR-T cell therapy.
• Existing study designs may not be sufficiently informative or efficient for complex immunotherapies.

Purpose of the Study:

• To develop an optimal experimental design framework for CAR-T cell therapy clinical studies.
• To create a robust and feasible study design by integrating a mechanistic model of CAR-T cell kinetics and tumor dynamics.
• To address parameter uncertainty and population variability in CAR-T cell therapy models.

Main Methods:

• Utilized a published mechanistic model of CAR-T cell kinetics and tumor dynamics.
• Employed optimal experimental design principles to identify minimal population size and efficient sampling strategies.
• Incorporated stochastic simulation and estimation to compare flexible sampling windows with fixed timepoints.

Main Results:

• Identified a minimal population size of 60 patients for model parameterization.
• Determined three optimal CAR-T cell sampling windows (days 2-4, 12-18, 32-47) and fixed tumor burden assessments (days 0, 30, 90).
• The optimized design with sampling windows demonstrated superior performance in informing model parameters, including those for heterogeneous outcomes, compared to fixed sampling designs.

Conclusions:

• The developed optimal experimental design framework enhances the efficiency and robustness of CAR-T cell therapy clinical trials.
• Flexible sampling windows improve data collection for modeling complex immunotherapies.
• This approach facilitates feasible and resource-efficient data collection, advancing CAR-T cell therapy development and clinical practice.